No Data
No Data
Corvus Pharmaceuticals | 10-Q: Quarterly report
Corvus Pharmaceuticals Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
Richard A Miller, Director, President and CEO, on May 06, 2024, executed a purchase for 577,634 shares in Corvus Pharmaceuticals (CRVS) for $1,000,000. Following the Form 4 filing with the SEC, Miller
Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q1 Financial Results.
Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q1 Financial Results.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer
Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer